soul trial oral semaglutide cardiovascular outcomes soul trial results 2025 The impact of on events in patients with type 2 diabetes: review of from the Canadian Perspectives 2025 Whiteboard on

My personal opinion only and very briefly so please don't nit-pick on anything I've said LOL Yes of course YOUR choice

Semaglutide 2.4 mg efficacy and safety in people with obesity and knee osteoarthritis: Results: From the STEP 9 randomised clinical trial

This activation triggers several glucose-lowering mechanisms: Enhanced insulin secretion : These agents stimulate insulin release from pancreatic beta cells in a glucose-dependent manner, meaning insulin secretion increases only when blood glucose levels are elevated, reducing hypoglycaemia risk

They function as signaling molecules in the body, influencing processes ranging from tissue repair to hormone secretion to immune function